News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biota, Inc. Announces Royalties from Inavir(R) and Relenza(TM) for Q4 and F2011


8/1/2011 8:38:28 AM

MELBOURNE, Australia--(BUSINESS WIRE)--Biota Holdings Limited (ASX:BTA) announces that it has received written notifications from GlaxoSmithKline (GSK) regarding royalties for Relenza™ and from Daiichi Sankyo for Inavir®. Indicative royalties from Relenza™ were $1.8m during the three months ended 30 June 2011. F2011 actual royalties are $6.6m. Royalties from of Inavir® were AUD 160k during the three months ended 30 June 2011, on sales of JPY 390m.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES